Financial Incentives for COVID-19 Vaccination
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2024.58542 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von John Ternovski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Office of Labor and Economic Analysis, Department of Economics and Geosciences, Air Force Academy, Colorado Springs, Colorado. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Motivation, Vaccination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Prior studies found that financial incentives have small, positive direct effects in increasing COVID-19 vaccination rates, but unmeasured social spillovers (ie, changes in outcomes among untreated individuals who are socially exposed to policy beneficiaries) may diminish the overall effect of such policies.
Objective
To assess the spillover effects of a COVID-19 vaccination financial incentive and assess whether incorporating estimates of spillover meaningfully affects broader evaluations of policy effectiveness. Design, Setting, and Participants This population-level, address-cluster randomized clinical trial was conducted in November 2021. Participants were all adult (aged ≥18 years) residents of Ravensburg, Germany, who were randomly assigned to the treatment or control group. One resident in each address cluster was randomly selected to be an address-cluster representative. Address-cluster representatives in the treatment group received the treatment letter; all other cohabitants at that same address received the control letter. All individuals in addresses randomly assigned to the control group were mailed a control letter. Intention-to-treat data analysis was conducted from January 2022 to May 2024.
Intervention
Control letters informed recipients about 7 upcoming free COVID-19 vaccination events. Treatment letters were identical to control letters, except they also offered €40 (US $41.46) for getting vaccinated at one of the events. Main Outcome and Measure Primary and booster COVID-19 vaccination uptake was observed and recorded on site during the public vaccination events. Primary vaccinations were defined as either the first dose of a 1-dose vaccine or the first or second dose of a 2-doses vaccine. Boosters were defined as any dose after primary vaccination. Three types of commonly used treatment effects were analyzed: direct, spillover, and overall.
Results
Among 41 548 Ravensburg residents (mean [SD] age, 49.96 [19.04] years; 51.3% female), 796 (1.9%) were vaccinated at 1 of the 7 public vaccination events. The direct, spillover, and overall effects of receiving a financial incentive on primary vaccinations were all nonsignificant. For booster vaccinations, the direct effect was negative but not statistically significant (−0.32 percentage points [95% CI, −0.77 to 0.14 percentage points]; P = .17), whereas the overall effect (−0.30 percentage points [95% CI, −0.51 to −0.09 percentage points]; P = .006) was significantly negative. The spillover effect was significantly negative (−0.29 percentage points [95% CI, −0.53 to −0.06 percentage points]; P = .01), but only for the first vaccination events. Conclusions and Relevance This trial found null direct effects on COVID-19 vaccination uptake and negative effects on booster uptake among individuals who did not receive but were indirectly exposed to the financial incentives. The timing of this spillover suggests that cohabitants of financial incentive recipients postponed booster vaccination, thereby undermining the potential effectiveness of this policy. Trial Registration ISRCTN identifier: ISRCTN59503725
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of Labor and Economic Analysis, Department of Economics and Geosciences, Air Force Academy, Colorado Springs, Colorado.
- McCourt School of Public Policy, Georgetown University, Washington, DC.
- Department of Political Science, Aarhus University, Aarhus, Denmark.
- Department of Political and Social Sciences, Zeppelin University, Friedrichshafen, Germany.
- Department of Administrative Sciences, Harz University of Applied Sciences, Halberstadt, Germany.
Zitieren
APA
Ternovski, J., Jilke, S., Keppeler, F., & Vogel, D. (2025). Financial Incentives for COVID-19 Vaccination. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.58542
Vancouver
Ternovski J, Jilke S, Keppeler F, Vogel D. Financial Incentives for COVID-19 Vaccination. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2024.58542
BibTeX
@article{Ternovski2025,
author = {Ternovski, John and Jilke, Sebastian and Keppeler, Florian and Vogel, Dominik},
title = {Financial Incentives for COVID-19 Vaccination},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2024.58542}
}
EUVIMED